Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.
about
The biochemical and mass spectrometric profiling of the dystrophin complexome from skeletal muscleProteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.Differential β-glucosidase expression as a function of carbon source availability in Talaromyces amestolkiae: a genomic and proteomic approach.Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy.mRNA and microRNA transcriptomics analyses in a murine model of dystrophin loss and therapeutic restoration.Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy.Understanding the molecular consequences of inherited muscular dystrophies: advancements through proteomic experimentation.Peroxisome Proliferator-activated Receptor γ Coactivator-1 α Isoforms Selectively Regulate Multiple Splicing Events on Target GenesProteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin.RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect.Noncoding RNAs and Duchenne muscular dystrophy.Proteomic profiling of muscle fibre type shifting in neuromuscular diseases.Comparative gel-based proteomic analysis of chemically crosslinked complexes in dystrophic skeletal muscle.Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMD
P2860
Q26770343-65353A76-810E-44C8-89F5-B3CE780073B2Q33675040-64BCA925-99DF-4170-9F45-C73B6A95C449Q33827269-620B39DB-B9E6-4663-A130-BEC2EC466D54Q36305436-ED9DD95F-2CE2-43EB-A0DB-50CBF1F3FF9BQ38717697-7DF22AB4-16B3-4372-90DD-E8FCECFD047CQ38783823-5C43A5B4-F98A-4207-8E59-1AC3AFB5C6E9Q38820669-D581833A-BF44-43B6-B856-2AF4757A1F24Q38850056-F5834E0D-8C49-4B48-8B27-22A4CCA4318AQ42417216-26B063CB-2516-4C29-BD1D-6AB3AD280C61Q47959546-C29AF610-5BBF-4946-9ADC-86D991AC697CQ49196789-78515312-3DFD-455F-BFA0-22F8965C9F47Q50479884-36D842B5-8D8C-4921-A553-D02D76511AF5Q51664676-AE1F3C43-EFB1-40BD-A21F-4F546CA7048AQ52313732-A8E0FC0F-DD67-46CC-85CC-0C6AB7E1594AQ58767734-FB987FDD-0614-4FA1-A304-E05C454204D6
P2860
Multi-level omics analysis in a murine model of dystrophin loss and therapeutic restoration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Multi-level omics analysis in ...... s and therapeutic restoration.
@ast
Multi-level omics analysis in ...... s and therapeutic restoration.
@en
type
label
Multi-level omics analysis in ...... s and therapeutic restoration.
@ast
Multi-level omics analysis in ...... s and therapeutic restoration.
@en
prefLabel
Multi-level omics analysis in ...... s and therapeutic restoration.
@ast
Multi-level omics analysis in ...... s and therapeutic restoration.
@en
P2093
P2860
P50
P356
P1476
Multi-level omics analysis in ...... ss and therapeutic restoration
@en
P2093
C I Edvard Smith
Caroline Godfrey
Graham McClorey
K Emelie M Blomberg
Michael J Gait
Samir El Andaloussi
Thibault Coursindel
Thomas C Roberts
P2860
P304
P356
10.1093/HMG/DDV381
P577
2015-09-18T00:00:00Z